Cargando…

Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is associated with increased oxidative and nitrosative stress. The aim of our study was to assess the importance of these factors in the airways of healthy smokers and symptomatic smokers without airway obstruction, i.e. individuals with GOLD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rytilä, Paula, Rehn, Tiina, Ilumets, Helen, Rouhos, Annamari, Sovijärvi, Anssi, Myllärniemi, Marjukka, Kinnula, Vuokko L
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1524947/ https://www.ncbi.nlm.nih.gov/pubmed/16646959 http://dx.doi.org/10.1186/1465-9921-7-69

Ejemplares similares

Matrix metalloproteinases -8, -9 and -12 in smokers and patients with Stage 0 COPD
por: Ilumets, Helen, et al.
Publicado: (2007)

Repeatability of exhaled nitric oxide measurements in patients with COPD
por: Rouhos, Annamari, et al.
Publicado: (2011)

Hemoglobin α and β are ubiquitous in the human lung, decline in idiopathic pulmonary fibrosis but not in COPD
por: Ishikawa, Nobuhisa, et al.
Publicado: (2010)

Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: Current and future perspectives
por: Louhelainen, Noora, et al.
Publicado: (2008)

Modulation of glutaredoxin in the lung and sputum of cigarette smokers and chronic obstructive pulmonary disease
por: Peltoniemi, Mirva J, et al.
Publicado: (2006)

Atopic sensitization to common allergens without symptoms or signs of airway disorders does not increase exhaled nitric oxide
por: Rouhos, Annamari, et al.
Publicado: (2008)

Persistence of oxidant and protease burden in the airways after smoking cessation
por: Louhelainen, Noora, et al.
Publicado: (2009)

Glutathione S-transferase omega in the lung and sputum supernatants of COPD patients
por: Harju, Terttu H, et al.
Publicado: (2007)

Elevation of sputum matrix metalloproteinase-9 persists up to 6 months after smoking cessation: a research study
por: Louhelainen, Noora, et al.
Publicado: (2010)

Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction
por: Ilumets, Helen, et al.
Publicado: (2011)

Variability in the precursor proteins of collagen I and III in different stages of COPD
por: Harju, Terttu, et al.
Publicado: (2010)

Glutathione-S-transferases in lung and sputum specimens, effects of smoking and COPD severity
por: Harju, Terttu, et al.
Publicado: (2008)

From GOLD 0 to Pre-COPD
por: Han, MeiLan K., et al.
Publicado: (2021)

Pharmacological treatment of idiopathic pulmonary fibrosis – preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine
por: Myllärniemi, Marjukka, et al.
Publicado: (2015)

mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis
por: Rajala, Kaisa, et al.
Publicado: (2017)

Comparison between the disease-specific Airways Questionnaire 20 and the generic 15D instruments in COPD
por: Mazur, Witold, et al.
Publicado: (2011)

Diffuse Alveolar Damage: A Common Phenomenon in Progressive Interstitial Lung Disorders
por: Kaarteenaho, Riitta, et al.
Publicado: (2011)

Apoptotic mechanisms in the pathogenesis of COPD
por: Plataki, Maria, et al.
Publicado: (2006)

Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study
por: Terzikhan, Natalie, et al.
Publicado: (2016)

High prevalence of rhinitis symptoms without allergic sensitization in Estonia and Finland
por: Pallasaho, Paula, et al.
Publicado: (2015)

Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study
por: Zhang, Jing, et al.
Publicado: (2014)

Serum Metabolite Biomarkers Discriminate Healthy Smokers from COPD Smokers
por: Chen, Qiuying, et al.
Publicado: (2015)

Predictors of COPD in symptomatic smokers and ex-smokers seen in primary care
por: Tupper, Oliver Djurhuus, et al.
Publicado: (2018)

COVID-19 Disease Course in Former Smokers, Smokers and COPD Patients
por: Alberca, Ricardo Wesley, et al.
Publicado: (2021)

Dental Health in Smokers with and without COPD
por: Bergström, Jan, et al.
Publicado: (2013)

Smoking, environmental tobacco smoke and occupational irritants increase the risk of chronic rhinitis
por: Hisinger-Mölkänen, Hanna, et al.
Publicado: (2018)

Overall drug treatment of idiopathic pulmonary fibrosis patients from national registries – a real-world study from Finland
por: Kaunisto, Jaana, et al.
Publicado: (2023)

T(1) Relaxation Time in Lungs of Asymptomatic Smokers
por: Alamidi, Daniel F., et al.
Publicado: (2016)

Bronchial hyperresponsiveness in an adult population in Helsinki: decreased FEV(1), the main determinant
por: Juusela, Maria, et al.
Publicado: (2013)

Increase in prevalence of physician-diagnosed asthma in Helsinki during the Finnish Asthma Programme: improved recognition of asthma in primary care? A cross-sectional cohort study
por: Kainu, Annette, et al.
Publicado: (2013)

Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD
por: Babusyte, Agne, et al.
Publicado: (2007)

Prevalence of abnormal findings when adopting new national and international Global Lung Function Initiative reference values for spirometry in the Finnish general population
por: Kainu, Annette, et al.
Publicado: (2016)

Nitric oxide-induced eosinophil apoptosis is dependent on mitochondrial permeability transition (mPT), JNK and oxidative stress: apoptosis is preceded but not mediated by early mPT-dependent JNK activation
por: Ilmarinen-Salo, Pinja, et al.
Publicado: (2012)

Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD
por: Erb-Downward, John R., et al.
Publicado: (2011)

Physiological and biological characterization of smokers with and without COPD
por: Chaudhary, Nveed, et al.
Publicado: (2018)

Flavonoid intakes inversely associate with COPD in smokers
por: Bondonno, Nicola P., et al.
Publicado: (2022)

2011 GOLD Stages of COPD: Transitions, Predictor Factors and Comparison with 2017 GOLD Stages
por: Bernabeu-Mora, Roberto, et al.
Publicado: (2020)

Steroid Resistance in COPD? Overlap and Differential Anti-Inflammatory Effects in Smokers and Ex-Smokers
por: Hoonhorst, Susan J. M., et al.
Publicado: (2014)

Constant-load exercise decreases the serum concentration of myeloperoxidase in healthy smokers and smokers with COPD
por: Holz, Olaf, et al.
Publicado: (2015)

Prevalence of chronic obstructive pulmonary disease in asymptomatic smokers
por: Sansores, Raúl H, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2p5klo3baoh275jb35hnainm6o